Rabbit Recombinant Monoclonal Adropin antibody. Carrier free. Suitable for IP, WB and reacts with Rat, Mouse, Human samples.
Constituents: 100% PBS
ICC/IF | IP | WB | IHC-P | IHC-Fr | Flow Cyt (Intra) | |
---|---|---|---|---|---|---|
Human | Not recommended | Not recommended | Tested | Not recommended | Not recommended | Not recommended |
Mouse | Not recommended | Tested | Tested | Not recommended | Not recommended | Not recommended |
Rat | Not recommended | Tested | Tested | Not recommended | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat, Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Involved in the regulation of glucose homeostasis and lipid metabolism.
C9orf165, UNQ470/PRO830, ENHO, Adropin, Energy homeostasis-associated protein
Rabbit Recombinant Monoclonal Adropin antibody. Carrier free. Suitable for IP, WB and reacts with Rat, Mouse, Human samples.
Constituents: 100% PBS
ab279721 is the carrier-free version of Anti-Adropin antibody [EPR24382-57] ab279716.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Adropin is a secreted peptide hormone also known as Energy Homeostasis Associated (ENHO) gene product. This protein has a mass of approximately 4.5 kDa and is primarily expressed in the liver and brain but also in the pancreas and various peripheral tissues. Adropin plays a role in regulating metabolic homeostasis influencing lipid metabolism and glucose levels through its action. It facilitates communication within cells to maintain energy balance and research shows its involvement in modulating insulin sensitivity.
Adropin influences glucose homeostasis and fatty acid metabolism. It does not form part of a larger complex but functions as a solitary signaling molecule. The protein impacts cellular processes by increasing glucose oxidation and reducing fatty acid oxidation contributing to energy balance. Studies have demonstrated its role in influencing cardiovascular functions and central nervous systems processes which link it to various metabolic conditions.
Adropin is involved in the regulation of energy balance through the insulin signaling pathway and the AMPK pathway. Both pathways help manage glucose uptake and energy expenditure. In the insulin signaling pathway adropin works alongside other proteins like PPARγ and GLUT4 to control glucose levels. Adropin's role in the AMPK pathway relates to cellular energy charge and helps maintain metabolic health by modulating lipid and glucose metabolism.
Adropin has potential links to obesity and type 2 diabetes where it might contribute to pathophysiologies. Its reduced levels are often observed in patients with these conditions. The association to disorders involves interaction with proteins such as insulin receptor substrate (IRS) and adiponectin which mediate metabolic responses affecting glucose and lipid homeostasis. Understanding adropin's actions in these contexts could assist in the development of novel therapeutic strategies targeting metabolic disorders.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-Adropin antibody [EPR24382-57] ab279716, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration: 5% NFDM/TBST
Exposure time: 8 seconds
All lanes: Western blot - Anti-Adropin antibody [EPR24382-57] (Anti-Adropin antibody [EPR24382-57] ab279716) at 1/1000 dilution
All lanes: Human Adropin Recombinant Protein (aa38-79) with a His6-ABP tag at 10 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Predicted band size: 8 kDa
Observed band size: 22 kDa
This data was developed using Anti-Adropin antibody [EPR24382-57] ab279716, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration: 5% NFDM/TBST
This blot was developed using a higher sensitivity ECL substrate.
Exposure time: 3 minutes
All lanes: Western blot - Anti-Adropin antibody [EPR24382-57] (Anti-Adropin antibody [EPR24382-57] ab279716) at 1/1000 dilution
All lanes: Human cerebellum tissue lysate at 20 µg
All lanes: Western blot - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/1000 dilution
Predicted band size: 8 kDa
Observed band size: 15 kDa
This data was developed using Anti-Adropin antibody [EPR24382-57] ab279716, the same antibody clone in a different buffer formulation.
Adropin was immunoprecipitated from 0.35 mg Mouse brain tissue lysate with Anti-Adropin antibody [EPR24382-57] ab279716 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using Anti-Adropin antibody [EPR24382-57] ab279716 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
Lane 1: Mouse brain tissue lysate 10 ug
Lane 2: Anti-Adropin antibody [EPR24382-57] ab279716 IP in Mouse brain tissue lysate
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of Anti-Adropin antibody [EPR24382-57] ab279716 in mouse brain tissue lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 6 seconds
All lanes: Immunoprecipitation - Anti-Adropin antibody [EPR24382-57] (Anti-Adropin antibody [EPR24382-57] ab279716)
Predicted band size: 8 kDa
Observed band size: 15 kDa
This data was developed using Anti-Adropin antibody [EPR24382-57] ab279716, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration: 5% NFDM/TBST
Low expression tissues: lung, kidney (PMID:25074942).
The expression profile / molecular weight observed is consistent with what has been described in the literature (PMID:25074942).
Exposure time: 3 minutes
All lanes: Western blot - Anti-Adropin antibody [EPR24382-57] (Anti-Adropin antibody [EPR24382-57] ab279716) at 1/1000 dilution
Lane 1: Mouse brain tissue lysate at 20 µg
Lane 2: Mouse cerebellum tissue lysate at 20 µg
Lane 3: Mouse kidney tissue lysate at 20 µg
Lane 4: Mouse lung tissue lysate at 20 µg
Lane 5: Rat brain tissue lysate at 20 µg
Lane 6: Rat lung tissue lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/50000 dilution
Predicted band size: 8 kDa
Observed band size: 15 kDa, 17 kDa
This data was developed using Anti-Adropin antibody [EPR24382-57] ab279716, the same antibody clone in a different buffer formulation.
Adropin was immunoprecipitated from 0.35 mg Rat brain tissue lysate with Anti-Adropin antibody [EPR24382-57] ab279716 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using Anti-Adropin antibody [EPR24382-57] ab279716 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
Lane 1: Rat brain tissue lysate 10 ug
Lane 2: Anti-Adropin antibody [EPR24382-57] ab279716 IP in Rat brain tissue lysate
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of Anti-Adropin antibody [EPR24382-57] ab279716 in rat brain tissue lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 8 seconds
All lanes: Immunoprecipitation - Anti-Adropin antibody [EPR24382-57] (Anti-Adropin antibody [EPR24382-57] ab279716)
Predicted band size: 8 kDa
Observed band size: 15 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com